MICHELE TAFFARO-NESKEY: Open Payments
NPI 1982755781 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$291 in 12 payments from 11 companies in 2025. Trend: 2023 $310 · 2024 $245 · 2025 $291
Food & beverage: $291
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Merck Sharp & Dohme LLC | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Iovance Biotherapeutics, Inc. | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Incyte Corporation | 1 | $26 |
| Genmab U.S., Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| SERVIER PHARMACEUTICALS LLC | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: CALQUENCE, KEYTRUDA, Amtagvi, Nubeqa, MONJUVI, Epkinly, LIBTAYO, OPDIVO.
Industry payments across SC — which companies pay providers there.
